ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health policies, a trend contributing to what can be termed a “silent pandemic.” This perspective highlights the growing burden of cancer in aging populations in LMICs and critically examines the systemic gaps in prevention, diagnosis, treatment, survivorship care, and financial protection. Drawing on global and LMIC‐specific evidence, the article explores key challenges such as underdiagnosis, limited access to age‐sensitive screening, inadequate geriatric assessment, exclusion from clinical trials, and financial toxicity. It also provides evidence‐informed recommendations to strengthen geriatric oncology care in resource‐limited settings. These include integrating geriatric assessments into oncology practice, promoting age‐inclusive research, expanding survivorship care and community support systems, and implementing financial protection policies. Addressing this neglected area is essential to achieving equitable cancer control and ensuring healthy aging in LMICs.
Abdullateef et al. (Thu,) studied this question.